Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients

Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients

Natalizumab is currently one of the best options for treatment of patients with Multiple Sclerosis who have failed traditional prior therapies. However, prolonged use, prior immunosuppressive therapy and anti-JCV antibody status have been associated with increased risk of developing progressive mult...

Full description

Bibliographic Details
Main Authors: Luiz Henrique da Silva Nali, Lenira Moraes, Maria Cristina Domingues Fink, Dagoberto Callegaro, Camila Malta Romano, Augusto Cesar Penalva de Oliveira
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2014-12-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
esclerose múltipla
Natalizumabe
vírus JC
leucoencefalopatia multifocal progressiva
viruria
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014001200960&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014001200960&lng=en&tlng=en

Similar Items